Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

an) reports that Azerbaijan's Defense Ministry "accused Armenia of firing several ballistic missiles from its territory at the Azerbaijani cities of Gabala, Siyazan and Kurdamir, which are located far from the area of fighting in Nagorno-Karabakh." However, "The Armenian military rejected the claim as

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

an) reports that Azerbaijan's Defense Ministry "accused Armenia of firing several ballistic missiles from its territory at the Azerbaijani cities of Gabala, Siyazan and Kurdamir, which are located far from the area of fighting in Nagorno-Karabakh." However, "The Armenian military rejected the claim as a

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

an) reports that Azerbaijan's Defense Ministry "accused Armenia of firing several ballistic missiles from its territory at the Azerbaijani cities of Gabala, Siyazan and Kurdamir, which are located far from the area of fighting in Nagomo-Karabakh." However, "The Armenian military rejected the claim as a